About this journal

Drug Design, Development and Therapy is an Open Access peer-reviewed journal covering the spectrum of drug design, discovery, and development through to clinical applications. 

The journal’s audience includes pharmaceutical chemist, Clinicians, Principal investigators with academic and industry profiles interested in specific topics which include:

• Drug target identification and validation
• Phenotypic screening and target deconvolution
• Biochemical analyses of drug targets and their pathways
• New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
• Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
• Structural or molecular biological studies elucidating molecular recognition processes
• Fragment-based drug discovery
• Pharmaceutical/red biotechnology
• Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
• Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
• Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
• Preclinical development studies
• Translational animal models
• Mechanisms of action and signalling pathways
• Toxicology
• Gene therapy, cell therapy and immunotherapy
• Personalized medicine and pharmacogenomics
• Clinical drug evaluation
• Patient safety and sustained use of medicines

The journal provides an open access platform to outstanding reviews on drug efficacy, therapies, and drug profiles. We are proud our authors show high level of satisfaction based on engaged Editor in Chief and Editorial Board, a quality peer review, and a rapid decision making.

The journal welcomes for consideration the following paper types: original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. All articles received by the Journal will be subject to a single-anonymous peer review.

The journal does not accept study protocols or case reports.

*Computational modelling, in silico screening and molecular docking studies must be validated using appropriate in vitro or in vivo methods.

 **Plant extract studies will only be considered if the active compound has been identified and validated.

When considering submission of a paper utilizing publicly available data authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.

All authors who want to submit their work to Drug Design, Development and Therapy  must adhere to the guidelines provided in the Editorial titled ‘ Statistical Analysis in Clinical and Experimental Medical Research: Simplified Guidance for Authors and Reviewers’. The Editorial can be found here.

Read the

Editor-in-Chief

Frank M. Boeckler, Professor Medicinal Chemistry and Drug Design, Laboratory for Molecular Design and Pharmaceutical Biophysics, Department of Pharmaceutical and Medicine, Eberhard-Karls University Tuebingen, Tuebingen, Germany

Associate Editors-in-Chief

Tamer M. Ibrahim Abdelrehim, Associate Professor, Pharmaceutical Bioinformatics Department, Albert-Ludwigs-University of Freiburg, Germany

Tuo Deng, Assistant Professor of Medicine, Houston Methodist Research Institute, Houston, USA

Qiongyu Guo, Assistant Professor Drug delivery systems, Southern University of Science and Technology, Shenzhen, China

Anastasios Lymperopoulos, Professor Pharmacology, Nova Southeastern University, Fort Lauderdale, FL, USA

Manfred Ogris, Professor Pharmaceutical Sciences, University of Vienna, Vienna, Austria

Georgios D. Panos, MD, PhD Ophthalmology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Jianbo Sun, Professor and Director of Department of Scientific Research, First Dongguan Affiliated Hospital, Guangdong Medical University, China

Tin Wui Wong, Professor Non-Destructive Biomedical and Pharmaceuticology, University Teknologi MARA, Malaysia

Yan Zhu, Professor and Executive Associate Director, Tianjin University of Traditional Chinese, Tianjin, China

Editorial Board

Janice Aldrich-Wright, Professor, Deputy Dean, Graduate Research School, Academic lead of the WSU Science in Australia Gender Equity (SAGE) initiative, School of Science and Health, Conjoint Position School of Medicine, Western Sydney University, Australia

Francis Ali-Osman, Professor Dr. Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA

Mansoor Amiji, University Distinguished Professor and Director of the Laboratory for Biomaterials and Advanced Nano-Delivery Systems (BANDS), Department of Pharmaceutical Sciences, School of Pharmacy at Northeastern University in Boston, Massachusetts, USA

Soo Kyung Bae, Associate professor, College of Pharmacy, The Catholic University of Korea, Bucheon, Republic of Korea

Daniela Carbone, Assistant Professor, University of Palermo, Palermo, Italy

James M. Cook, University Distinguished Professor, University of Wisconsin-Milwaukee, Milwaukee, WI, USA

Wei Duan, Alfred Deakin Professor , Deakin University School of Medicine, Melbourne, Australia

Martin Egli, Professor, Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA

Sanjay Garg, Professor of Pharmaceutical Sciences, Co-Director, Centre for Pharmaceutical Innovation (CPI), University of South Australia, Adelaide, Australia

Beom-Jin Lee, Dean and Professor, College of Pharmacy, Ajou University, South Korea

David M. Lubman, Maude T. Lane Professor of Surgery, Professor of Pathology and Chemistry, University of Michigan, Ann Arbor, MI, USA

Cezary Marcinkiewicz, Adjunct Professor, Department of Bioengineering, Temple University, Philadelphia, USA

John J. Rossi, Lidow Family Research Chair, Professor, Department of Molecular Biology, Dean, Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA

Wolfgang Sadee, Dr.rer.nat, Professor Emeritus, Cancer Biology and Genetics, The Ohio State University and Professor Emeritus, Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, USA

Holger Stark, Univ.-Prof. Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universitaet Duesseldorf, Germany

Valter Travagli, Professor in Pharmaceutical Technology, Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy

Mark Trudell, Distinguished Professor and Chair, Department of Chemistry, University of New Orleans, Louisiana, USA

Gretchen M. Unger, Chief Scientific Officer, GeneSegues, Inc., Chaska, MN, USA

Scott Waldman, Professor and Chair, Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA

Michael J. Waring, Professor of Chemotherapy, University of Cambridge, Jesus College, Cambridge, UK

Junmin Zhang, Ph.D, School of Pharmacy & State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, China

News, offers and calls for papers